|
58
|
226
|
5l64H |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
67
|
242
|
5l69D |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
55
|
204
|
5lf1I |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
66
|
239
|
5lf7F |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
55
|
261
|
5ln3C |
The human 26s proteasome at 6.8 ang. |
|
62
|
241
|
5l67G |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
242
|
5m2bD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
59
|
196
|
5l67N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
61
|
222
|
5l64L |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
64
|
237
|
5lf1C |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
69
|
243
|
5l5tF |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
67
|
250
|
5m2bA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
60
|
195
|
5l68J |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
71
|
248
|
5le5B |
Native human 20s proteasome at 1.8 angstrom |
|
61
|
222
|
5l5uL |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
60
|
231
|
5l61E |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
66
|
250
|
5l62A |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
59
|
202
|
5leyN |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
66
|
213
|
5lexL |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
70
|
243
|
5l5xF |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
58
|
204
|
5l5zI |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
76
|
248
|
5leyB |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
68
|
240
|
5l6aC |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
64
|
227
|
5lzp0 |
Binding of the c-terminal gqyl motif of the bacterial proteasome activator bpa to the 20s proteasome |
|
54
|
196
|
5leyJ |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
64
|
241
|
5l5xG |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
66
|
216
|
5lf0M |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
62
|
244
|
5lf6G |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
67
|
242
|
5l62D |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
57
|
202
|
5lexN |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
67
|
230
|
5lf4A |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
68
|
211
|
5l61K |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
61
|
230
|
5lexA |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
66
|
250
|
5l5uA |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
74
|
248
|
5lf1B |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
55
|
248
|
5ln3D |
The human 26s proteasome at 6.8 ang. |
|
67
|
233
|
5l6bM |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
66
|
237
|
5lf4C |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
44
|
218
|
5ln37 |
The human 26s proteasome at 6.8 ang. |
|
58
|
204
|
5l6cI |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
66
|
240
|
5m2bC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
68
|
233
|
5l6cM |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
66
|
211
|
5l66K |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
58
|
226
|
5l5oH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
57
|
202
|
5lf4N |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
67
|
250
|
5l6aA |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
69
|
244
|
5l5xB |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
65
|
211
|
5l65K |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
70
|
243
|
5l68F |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
68
|
213
|
5lf3L |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
